|
Chronic Lymphocytic Leukemia Research Consortium
|
5P01CA081534-15
|
$3,807,607
|
$761,521
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
5P01CA154291-04
|
$3,698,322
|
$776,648
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
TCR Gene Modified T Cells for Adoptive Immunotherapy
|
5P01CA154778-05
|
$3,406,082
|
$1,873,345
|
NISHIMURA, MICHAEL
|
LOYOLA UNIVERSITY CHICAGO
|
|
Nano Approaches to Modulate Host Cell Response for Cancer Therapy
|
1U54CA198999-01
|
$2,261,936
|
$226,194
|
HUANG, LEAF
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
DF/HCC Kidney Cancer SPORE
|
2P50CA101942-11A1
|
$2,185,000
|
$262,200
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Duke SPORE in Brain Cancer
|
5P50CA190991-02
|
$2,185,000
|
$87,400
|
SAMPSON, JOHN
|
DUKE UNIVERSITY
|
|
SPORE: Brain Tumore SPORE Grant
|
5P50CA097257-13
|
$2,185,000
|
$109,250
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
SPORE in Skin Cancer
|
5P50CA174523-02
|
$2,185,000
|
$87,400
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
SPORE in Lymphoma
|
5P50CA126752-09
|
$2,184,999
|
$524,400
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-02
|
$2,184,998
|
$131,100
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Cervical Cancer
|
5P50CA098252-12
|
$2,174,869
|
$282,733
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer
|
5P50CA070907-17
|
$2,041,142
|
$408,228
|
MINNA, JOHN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
MOTILITY AND INVASION
|
6P01CA100324-13
|
$2,028,990
|
$202,899
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Hematopoietic Chimerism after Stem Cell Allografts
|
5P01CA078902-17
|
$2,019,079
|
$948,967
|
STORB, RAINER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biology and Transplantation of the Hematopoietic Stem Cell
|
2P01CA065493-21
|
$1,940,892
|
$426,996
|
WAGNER, JOHN
|
UNIVERSITY OF MINNESOTA
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-13
|
$1,932,287
|
$966,144
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Genitourinary Cancer
|
5P50CA091846-14
|
$1,930,400
|
$193,040
|
DINNEY, COLIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SPORE In Prostate Cancer
|
5P50CA092629-15
|
$1,901,412
|
$209,155
|
SCHER, HOWARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
SPORE in Prostate Cancer
|
5P50CA058236-20
|
$1,793,395
|
$358,679
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses
|
5P01CA177322-02
|
$1,743,351
|
$139,468
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,731,003
|
$692,401
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Gene therapy of cancer
|
ZIA BC 010985
|
$1,731,003
|
$692,401
|
Rosenberg, Steven
|
CCR (NCI)
|
|
MSKCC Center for Molecular Imaging in Cancer
|
5P50CA086438-15
|
$1,471,710
|
$382,645
|
LARSON, STEVEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-15
|
$1,428,925
|
$85,736
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Center for Molecular Imaging Research at MGH/HMS
|
5P50CA086355-16
|
$1,377,346
|
$55,094
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Lambda Genetic Networks and Lambda Red-Mediated Recombination
|
ZIA BC 010336
|
$1,208,087
|
$302,022
|
Court, Donald
|
CCR (NCI)
|
|
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
|
5P01CA066726-18
|
$1,182,811
|
$331,187
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Telomere Biology
|
ZIA BC 011519
|
$1,108,669
|
$22,173
|
Cooper, Julia
|
CCR (NCI)
|
|
Platform for MR-Guided Neurotherapeutic Drug Delivery
|
2R44CA177205-02
|
$938,975
|
$469,488
|
BARKER, EDWARD
|
INSERT, INC.
|
|
Uncover the mechanisms regulating the biogenesis and decay of miRNAs in cancer
|
ZIA BC 011566
|
$925,596
|
$277,679
|
Gu, Shuo
|
CCR (NCI)
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
3P50CA083639-15S1
|
$901,656
|
$108,199
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Pacific Ovarian Cancer Research Consortium
|
3P50CA083636-15S1
|
$901,655
|
$54,099
|
DRESCHER, CHARLES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors
|
5U54CA163167-05
|
$841,065
|
$92,517
|
HOLLAND, ERIC
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Initiation of DNA Replication in Mammalian Cells
|
ZIA BC 010411
|
$810,831
|
$121,625
|
Aladjem, Mirit
|
CCR (NCI)
|
|
Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
|
2P01CA016038-41A1
|
$775,523
|
$100,818
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
Clinical Trials of Immunotherapies for Childhood Cancer
|
ZIA BC 011498
|
$751,864
|
$300,745
|
Mackall, Crystal
|
CCR (NCI)
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$718,672
|
$718,672
|
Feldman, Steven
|
CCR (NCI)
|
|
Therapeutic Targeting of Malignant Glioma Stem Cells
|
1R35CA197725-01
|
$709,490
|
$354,745
|
LESNIAK, MACIEJ
|
UNIVERSITY OF CHICAGO
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$707,219
|
$212,166
|
Fry, Terry
|
CCR (NCI)
|
|
Cell Production Core Facility
|
ZIC BC 011569
|
$636,467
|
$318,234
|
Somerville, Robert
|
CCR (NCI)
|
|
Cell Prep Core
|
ZIC BC 010905
|
$636,466
|
$318,233
|
Wunderlich, John
|
CCR (NCI)
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural
|
1R01CA198076-01
|
$621,329
|
$310,665
|
PORTNOW, JANA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Liver Cancer Risk with rAAV Gene Therapy
|
1R01CA190144-01A1
|
$608,126
|
$608,126
|
GROMPE, MARKUS
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Leveraging Genetically-Engineered Mice to Optimize Pediatric Glioma Management
|
1R01CA195692-01
|
$584,882
|
$146,221
|
GUTMANN, DAVID
|
WASHINGTON UNIVERSITY
|
|
IMAGING T CELLS BY POSITRON EMISSION TOMOGRAPHY
|
5R01CA163587-04
|
$582,093
|
$291,047
|
NAJJAR, AMER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Histone Methyltransferases as a Target for Lung Cancer Prevention
|
5R01CA183296-02
|
$581,472
|
$290,736
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
Mechanisms of Chromosome Maintenance in Bacteria
|
ZIA BC 010277
|
$569,301
|
$56,930
|
Chattoraj, Dhruba
|
CCR (NCI)
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
2T32CA009515-31
|
$563,174
|
$563,174
|
PRESS, OLIVER
|
UNIVERSITY OF WASHINGTON
|
|
Targeted therapy of B cell malignances with CAR-T cells of defined composition
|
5R01CA136551-07
|
$560,424
|
$280,212
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Comparative Oncology Program
|
ZIG BC 011619
|
$539,097
|
$53,910
|
Leblanc, Amy
|
CCR (NCI)
|
Total relevant funding to Gene Therapy for this search: $39,508,420
|